Clinical trial finds that oral drug MK-0616 substantially reduces ‘bad’ cholesterol
MK-016 could offer another potential option to achieve guideline-recommended LDL-C levels resulting in reduction of cardiovascular risk.
Read more
atherosclerosis
The Cardiovascular Research Institute 8th Annual Symposium
Review the symposium highlights, visit the virtual poster session and meet the winners of the first Dr. Mark L. Entman Award for Excellence in Cardiovascular Education.
Read more
New insights from an autoimmunity-mediated atherosclerosis mouse model could pave the way to new therapies for cardiovascular diseases
By Ana María Rodríguez, Ph.D. Patients with autoimmune disease have a higher risk of developing atherosclerosis and cardiovascular disease. Although studies have shown that human atherosclerotic
Read more